Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University, No.169 Donghu Road, Wuchang District, Wuhan, 430071, China.
Department of Gastric and Colorectal Surgical Oncology, Zhongnan Hospital of Wuhan University, No.169 Donghu Road, Wuchang District, Wuhan, 430071, China.
Int J Biol Sci. 2022 Aug 16;18(14):5291-5308. doi: 10.7150/ijbs.73438. eCollection 2022.
Circulating tumor cells (CTCs) are important precursors of colorectal cancer (CRC) metastasis. The epithelial-mesenchymal transition (EMT) process facilitates CTC invasion by allowing these cells to evade antimetastatic checkpoints to mediate distant metastasis. However, the specific molecular mechanism of tumor EMT remains largely unknown. Based on our previous research on the YAP1 pathway, we further studied the upstream molecule small nucleolar RNA host gene 16 (SNHG16), whose expression was correlated with advanced TNM stage, distant metastasis, and poor prognosis in CRC patients. Furthermore, loss- and gain-of-function assays revealed that SNHG16 promoted CRC colony formation, proliferation, migration, invasion, EMT, mesenchymal-like CTC generation, and liver metastasis through YAP1. Mechanistically, SNHG16 acted as a miRNA sponge to sequester miR-195-5p on Ago2, thereby protecting YAP1 from repression. Moreover, YAP1 bound TEA domain transcription factor 1 (TEAD1) to form a YAP1/TEAD1 complex, which in turn bound two sites in the promoter of SNHG16 and regulate SNHG16 transcription. Finally, experiments showed that the inhibition of SNHG16 suppressed tumor progression, and that YAP1 rescued the effect of SNHG16 on tumor progression. Herein, we have clarified a hitherto unexplored SNHG16-YAP1/TEAD1 positive feedback loop, that may be a candidate target for CRC treatment.
循环肿瘤细胞(CTCs)是结直肠癌(CRC)转移的重要前体。上皮-间充质转化(EMT)过程通过允许这些细胞逃避抗转移检查点来介导远处转移,从而促进 CTC 的侵袭。然而,肿瘤 EMT 的具体分子机制在很大程度上仍然未知。基于我们之前对 YAP1 通路的研究,我们进一步研究了上游分子小核仁 RNA 宿主基因 16(SNHG16),其表达与 CRC 患者的晚期 TNM 分期、远处转移和不良预后相关。此外,缺失和获得功能实验表明,SNHG16 通过 YAP1 促进 CRC 集落形成、增殖、迁移、侵袭、EMT、间质样 CTC 生成和肝转移。在机制上,SNHG16 作为 miRNA 海绵与 Ago2 上的 miR-195-5p 结合,从而保护 YAP1 免受抑制。此外,YAP1 与 TEA 结构域转录因子 1(TEAD1)结合形成 YAP1/TEAD1 复合物,该复合物反过来结合 SNHG16 启动子中的两个位点并调节 SNHG16 转录。最后,实验表明抑制 SNHG16 抑制肿瘤进展,而 YAP1 挽救了 SNHG16 对肿瘤进展的影响。在此,我们阐明了一个迄今未知的 SNHG16-YAP1/TEAD1 正反馈回路,它可能是 CRC 治疗的候选靶点。